{
    "SPADE_N_14438": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_14438",
            "Peptide Name": "Ll-CATH (L. liui cathelicidin, UCSS1a; natural AMPs; toad, amphibians, animals; likely 3S=S)",
            "Source": "the Chongâ€™an Moustache Toad,Leptobrachium liui, China, Asia",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "SRPCNCRCCYVARGNGRCLLRPGCFTVAARPNRSV",
            "Sequence Length": 35,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Chemotactic",
                "Anti-inflammatory"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 3857.53,
            "PI": 9.99,
            "Hydrophobicity": -0.23,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Chen J, Zhang CY, Wang Y, Zhang L, Seah RWX, Ma L, Ding GH.2024",
                    "Reference": "BMC Vet Res. 2024 Aug 2;20(1):343. doi: 10.1186/s12917-024-04202-9.PubMed",
                    "Title": "Discovery of Ll-CATH: a novel cathelicidin from the Chong'an Moustache Toad (Leptobrachium liui) with antibacterial and immunomodulatory activity."
                }
            ],
            "Frequent Amino Acids": "RCA",
            "Absent Amino Acids": "DEHIKMOQUW",
            "Basic Residues": 7,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 13,
            "Polar Residues": 26,
            "Positive Residues": 7,
            "Negative Residues": 0,
            "Net Charge": 7,
            "Comments": "Peptide discovery: predicted cathelicidin based on sequence alingment.Host expression: mainly expressed in spleen of the toad.Sequence analysis: APD analysis reveals that this sequence shows low similarity (38.1%) toPhD1R: 20%, C: 17%.Activity: Active against A.hydrophila ATCC7966 (MIC >100 ug/ml), E.coli K12 (MIC > 100 ug/ml), L.monocytogenes ATCC19115 (MIC >100 ug/ml), P. mirabilis ATCC25933 (MIC 100 ug/ml), S.enterica ATCC13076 (MIC > 100 ug/ml), S. epidermidis ATCC12228 (MIC 12.5 ug/ml), S.iniae ATCC29178 (MIC > 100 ug/ml), V. harveyi ATCC33866 (MIC 25 ug/ml), V. parahaemolyticus ATCC33847 (MIC 100 ug/ml), and V. vulnifcus ATCC279562 (MIC 3.75 ug/ml). I\n Anti-inflammatory: Ll-CATH treatment decreased TNF-alpha and il-1beta expression in RAW264.7 cells (only at high concentration, to be confirmed).",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_26395",
                    "Similarity": 1.0,
                    "Sequence": "SRPCNCRCCYVARGNGRCLLRPGCFTVAARPNRSV"
                }
            ]
        }
    }
}